XW0336CIntroduction of Landiolol Antiarrhythmic into Peripheral Vein, Percutaneous Approach, New Technology Group 12
- Billable / Specific Code
- New for FY 2027
XW0336C is a billable ICD-10-PCS procedure code for Introduction of Landiolol Antiarrhythmic into Peripheral Vein, Percutaneous Approach, New Technology Group 12. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | W | Anatomical Regions |
| 3 | Operation | 0 | Introduction |
| 4 | BodyPart | 3 | Peripheral Vein |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | 6 | Landiolol Antiarrhythmic |
| 7 | Qualifier | C | New Technology Group 12 |
In the ICD-10-PCS Alphabetic Index
These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:
Code History
- 3E033RZ — Introduce of Antiarrhythmic into Periph Vein, Perc Approach
Similar Procedure Codes
Questions About XW0336C
Is XW0336C a billable code?
Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Landiolol Antiarrhythmic into Peripheral Vein, Percutaneous Approach, New Technology Group 12 on inpatient claims from October 1, 2026 through September 30, 2027.
What do the characters in XW0336C mean?
The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 3 is the BodyPart (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character 6 is the Device/Substance/Technology (Landiolol Antiarrhythmic); the 7th character C is the Qualifier (New Technology Group 12).